Abstract P3-10-07: A 3-gene DNA methylation signature fails to predict response to bevacizumab in metastatic breast cancer patients treated within the TANIA phase III trialSP Gampenrieder, Richard Greil, Gabriel Rinnerthaler et al.|Cancer Research|2019Cited by 0